207 related articles for article (PubMed ID: 15471954)
1. Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-beta2 glycoprotein I antibodies.
Zhang J; McCrae KR
Blood; 2005 Mar; 105(5):1964-9. PubMed ID: 15471954
[TBL] [Abstract][Full Text] [Related]
2. Statins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype.
Meroni PL; Raschi E; Testoni C; Tincani A; Balestrieri G; Molteni R; Khamashta MA; Tremoli E; Camera M
Arthritis Rheum; 2001 Dec; 44(12):2870-8. PubMed ID: 11762948
[TBL] [Abstract][Full Text] [Related]
3. Annexin A2: biology and relevance to the antiphospholipid syndrome.
Cockrell E; Espinola RG; McCrae KR
Lupus; 2008 Oct; 17(10):943-51. PubMed ID: 18827060
[TBL] [Abstract][Full Text] [Related]
4. A novel pathway for human endothelial cell activation by antiphospholipid/anti-β2 glycoprotein I antibodies.
Allen KL; Fonseca FV; Betapudi V; Willard B; Zhang J; McCrae KR
Blood; 2012 Jan; 119(3):884-93. PubMed ID: 22106343
[TBL] [Abstract][Full Text] [Related]
5. Annexin A2: better left alone.
Wolberg AS; Roubey RA
Blood; 2005 Mar; 105(5):1845-6. PubMed ID: 15747402
[TBL] [Abstract][Full Text] [Related]
6. Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids.
Takeya H; Mori T; Gabazza EC; Kuroda K; Deguchi H; Matsuura E; Ichikawa K; Koike T; Suzuki K
J Clin Invest; 1997 May; 99(9):2260-8. PubMed ID: 9151800
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 4 and β2 glycoprotein I interaction on endothelial cells.
Borghi MO; Raschi E; Grossi C; Chighizola CB; Meroni PL
Lupus; 2014 Oct; 23(12):1302-4. PubMed ID: 25228733
[TBL] [Abstract][Full Text] [Related]
8. Anti-β2GPI antibodies stimulate endothelial cell microparticle release via a nonmuscle myosin II motor protein-dependent pathway.
Betapudi V; Lominadze G; Hsi L; Willard B; Wu M; McCrae KR
Blood; 2013 Nov; 122(23):3808-17. PubMed ID: 23954892
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of anti-beta2-glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome.
George J; Blank M; Levy Y; Meroni P; Damianovich M; Tincani A; Shoenfeld Y
Circulation; 1998 Mar; 97(9):900-6. PubMed ID: 9521339
[TBL] [Abstract][Full Text] [Related]
10. β2-glycoprotein I, lipopolysaccharide and endothelial TLR4: three players in the two hit theory for anti-phospholipid-mediated thrombosis.
Raschi E; Chighizola CB; Grossi C; Ronda N; Gatti R; Meroni PL; Borghi MO
J Autoimmun; 2014 Dec; 55():42-50. PubMed ID: 24685231
[TBL] [Abstract][Full Text] [Related]
11. Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo.
Romay-Penabad Z; Montiel-Manzano MG; Shilagard T; Papalardo E; Vargas G; Deora AB; Wang M; Jacovina AT; Garcia-Latorre E; Reyes-Maldonado E; Hajjar KA; Pierangeli SS
Blood; 2009 Oct; 114(14):3074-83. PubMed ID: 19628708
[TBL] [Abstract][Full Text] [Related]
12. GDKV-induced antiphospholipid antibodies enhance thrombosis and activate endothelial cells in vivo and in vitro.
Gharavi AE; Pierangeli SS; Colden-Stanfield M; Liu XW; Espinola RG; Harris EN
J Immunol; 1999 Sep; 163(5):2922-7. PubMed ID: 10453040
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome.
Cesarman-Maus G; Ríos-Luna NP; Deora AB; Huang B; Villa R; Cravioto Mdel C; Alarcón-Segovia D; Sánchez-Guerrero J; Hajjar KA
Blood; 2006 Jun; 107(11):4375-82. PubMed ID: 16493010
[TBL] [Abstract][Full Text] [Related]
14. Beta2-glycoprotein I, anti-beta2-glycoprotein I, and fibrinolysis.
Yasuda S; Atsumi T; Ieko M; Koike T
Thromb Res; 2004; 114(5-6):461-5. PubMed ID: 15507279
[TBL] [Abstract][Full Text] [Related]
15. Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies.
Raschi E; Testoni C; Bosisio D; Borghi MO; Koike T; Mantovani A; Meroni PL
Blood; 2003 May; 101(9):3495-500. PubMed ID: 12531807
[TBL] [Abstract][Full Text] [Related]
16. Annexin A2 autoantibodies in thrombosis and autoimmune diseases.
Cañas F; Simonin L; Couturaud F; Renaudineau Y
Thromb Res; 2015 Feb; 135(2):226-30. PubMed ID: 25533130
[TBL] [Abstract][Full Text] [Related]
17. Anti-beta 2-glycoprotein I autoantibodies from patients with the "antiphospholipid" syndrome bind to beta 2-glycoprotein I with low affinity: dimerization of beta 2-glycoprotein I induces a significant increase in anti-beta 2-glycoprotein I antibody affinity.
Sheng Y; Kandiah DA; Krilis SA
J Immunol; 1998 Aug; 161(4):2038-43. PubMed ID: 9712077
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of a non-phospholipid-binding form of beta2-glycoprotein I in human plasma--consequences for the development of anti-beta2-glycoprotein I antibodies.
Horbach DA; van Oort E; Tempelman MJ; Derksen RH; de Groot PG
Thromb Haemost; 1998 Nov; 80(5):791-7. PubMed ID: 9843173
[TBL] [Abstract][Full Text] [Related]
19. High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin II.
Ma K; Simantov R; Zhang JC; Silverstein R; Hajjar KA; McCrae KR
J Biol Chem; 2000 May; 275(20):15541-8. PubMed ID: 10809787
[TBL] [Abstract][Full Text] [Related]
20. The role of beta2-glycoprotein I (beta2GPI) in the activation of plasminogen.
López-Lira F; Rosales-León L; Martínez VM; Ruiz Ordaz BH
Biochim Biophys Acta; 2006 Apr; 1764(4):815-23. PubMed ID: 16480936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
